Sundrug Co.,Ltd. (SDGCF)
USD 28.18
(-9.01%)
USD 28.18
(-9.01%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 29.12 Billion JPY | 14954.8% |
| 2023 | 193.46 Million JPY | -1.27% |
| 2022 | 195.95 Million JPY | -14.51% |
| 2021 | 229.22 Million JPY | 4.45% |
| 2020 | 219.46 Million JPY | 1.5% |
| 2019 | 216.22 Million JPY | -7.38% |
| 2018 | 233.46 Million JPY | 11.59% |
| 2017 | 209.2 Million JPY | 9.02% |
| 2016 | 191.9 Million JPY | -98.83% |
| 2015 | 16.36 Billion JPY | 3.86% |
| 2014 | 15.75 Billion JPY | 5.34% |
| 2013 | 14.95 Billion JPY | 18.88% |
| 2012 | 12.58 Billion JPY | 15.72% |
| 2011 | 10.87 Billion JPY | 15.16% |
| 2010 | 9.44 Billion JPY | 5.85% |
| 2009 | 8.91 Billion JPY | 15.73% |
| 2008 | 7.7 Billion JPY | 2.86% |
| 2007 | 7.49 Billion JPY | 2.36% |
| 2006 | 7.31 Billion JPY | 10.48% |
| 2005 | 6.62 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 61.84 Million JPY | 29.19% |
| 2024 Q1 | 47.8 Million JPY | 18.95% |
| 2024 Q2 | 47.87 Million JPY | 0.15% |
| 2024 Q4 | 6.34 Billion JPY | 10158.98% |
| 2024 FY | 29.12 Billion JPY | 14954.8% |
| 2023 FY | 193.46 Million JPY | -1.27% |
| 2023 Q3 | 58.26 Million JPY | 31.31% |
| 2023 Q2 | 44.37 Million JPY | -4.33% |
| 2023 Q1 | 46.37 Million JPY | 16.43% |
| 2023 Q4 | 40.18 Million JPY | -31.02% |
| 2022 Q2 | 50.79 Million JPY | -17.1% |
| 2022 Q1 | 61.27 Million JPY | 47.07% |
| 2022 Q3 | 56.88 Million JPY | 11.99% |
| 2022 Q4 | 39.83 Million JPY | -29.97% |
| 2022 FY | 195.95 Million JPY | -14.51% |
| 2021 Q2 | 6.42 Billion JPY | -8.85% |
| 2021 FY | 229.22 Million JPY | 4.45% |
| 2021 Q1 | 7.05 Billion JPY | 50.09% |
| 2021 Q4 | 41.66 Million JPY | -99.43% |
| 2021 Q3 | 7.24 Billion JPY | 12.76% |
| 2020 Q2 | 6.98 Billion JPY | 6.82% |
| 2020 FY | 219.46 Million JPY | 1.5% |
| 2020 Q1 | 6.54 Billion JPY | 17.47% |
| 2020 Q3 | 5.46 Billion JPY | -21.85% |
| 2020 Q4 | 4.69 Billion JPY | -13.99% |
| 2019 FY | 216.22 Million JPY | -7.38% |
| 2019 Q1 | 6.13 Billion JPY | 3.53% |
| 2019 Q2 | 5.58 Billion JPY | -8.88% |
| 2019 Q3 | 6.64 Billion JPY | 18.8% |
| 2019 Q4 | 5.57 Billion JPY | -16.11% |
| 2018 Q4 | 5.92 Billion JPY | -14.21% |
| 2018 Q3 | 6.9 Billion JPY | 15.43% |
| 2018 Q2 | 5.98 Billion JPY | -0.53% |
| 2018 Q1 | 6.01 Billion JPY | 5.79% |
| 2018 FY | 233.46 Million JPY | 11.59% |
| 2017 FY | 209.2 Million JPY | 9.02% |
| 2017 Q3 | 6.47 Billion JPY | 17.4% |
| 2017 Q2 | 5.51 Billion JPY | -2.32% |
| 2017 Q1 | 5.64 Billion JPY | 11.57% |
| 2017 Q4 | 5.68 Billion JPY | -12.13% |
| 2016 FY | 191.9 Million JPY | -98.83% |
| 2016 Q2 | 5.5 Billion JPY | 9.95% |
| 2016 Q1 | 5 Billion JPY | 14.53% |
| 2016 Q3 | 6 Billion JPY | 9.09% |
| 2016 Q4 | 5.05 Billion JPY | -15.74% |
| 2015 FY | 16.36 Billion JPY | 3.86% |
| 2015 Q1 | 3.31 Billion JPY | 5.78% |
| 2015 Q4 | 4.37 Billion JPY | -14.2% |
| 2015 Q3 | 5.09 Billion JPY | 41.95% |
| 2015 Q2 | 3.58 Billion JPY | 8.37% |
| 2014 Q4 | 3.13 Billion JPY | -28.21% |
| 2014 FY | 15.75 Billion JPY | 5.34% |
| 2014 Q1 | 3.89 Billion JPY | 5.04% |
| 2014 Q2 | 4.36 Billion JPY | 12.01% |
| 2014 Q3 | 4.36 Billion JPY | -0.14% |
| 2013 Q4 | 3.71 Billion JPY | -7.82% |
| 2013 FY | 14.95 Billion JPY | 18.88% |
| 2013 Q1 | 3.27 Billion JPY | -5.13% |
| 2013 Q2 | 3.94 Billion JPY | 20.6% |
| 2013 Q3 | 4.02 Billion JPY | 2.03% |
| 2012 Q3 | 3 Billion JPY | -5.98% |
| 2012 Q2 | 3.19 Billion JPY | 8.86% |
| 2012 Q1 | 2.93 Billion JPY | -6.74% |
| 2012 FY | 12.58 Billion JPY | 15.72% |
| 2012 Q4 | 3.44 Billion JPY | 14.85% |
| 2011 Q1 | 1.9 Billion JPY | -17.09% |
| 2011 Q3 | 3.04 Billion JPY | 9.88% |
| 2011 Q2 | 2.77 Billion JPY | 45.44% |
| 2011 FY | 10.87 Billion JPY | 15.16% |
| 2011 Q4 | 3.14 Billion JPY | 3.28% |
| 2010 Q3 | 2.28 Billion JPY | -14.2% |
| 2010 Q1 | 2.19 Billion JPY | 0.0% |
| 2010 FY | 9.44 Billion JPY | 5.85% |
| 2010 Q4 | 2.29 Billion JPY | 0.66% |
| 2010 Q2 | 2.66 Billion JPY | 21.33% |
| 2009 FY | 8.91 Billion JPY | 15.73% |
| 2008 FY | 7.7 Billion JPY | 2.86% |
| 2007 FY | 7.49 Billion JPY | 2.36% |
| 2006 FY | 7.31 Billion JPY | 10.48% |
| 2005 FY | 6.62 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -3703.18 USD | 786513312.968% |
| Allstar Health Brands, Inc. | -499.34 Thousand USD | 5832964.384% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 69.18 Million USD | -41997.799% |
| Café Serendipity Holdings, Inc. | -750.15 Thousand USD | 3882753.898% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | -49.02 Thousand USD | 59414240.59% |
| HealthWarehouse.com, Inc. | -1.77 Million USD | 1642315.181% |
| LIGAND PHARMACEUTICAL INC | 52.15 Million USD | -55746.148% |
| MedGen, Inc. | -15.54 USD | 187425997525.997% |
| Omni Health, Inc. | 1.26 Million USD | -2301188.124% |
| Oxford Investments Holdings Inc. | -299.1 Thousand USD | 9737882.637% |
| Pineapple, Inc. | -1.47 Million USD | 1971221.44% |
| ScripsAmerica, Inc. | -4.73 Million USD | 615735.528% |